创始人介绍

Club member

张小虎,爱科诺生物,首席执行官


张小虎,爱科诺生物,首席执行官


个人简介:


1990年毕业于北京大学化学系,获理学学士学位。

1997年毕业于新泽西州立大学(Rutgers University-the State University of New Jersey)获化学博士学位。

1998-2000就职于Strategene, an Agilent Company, 任研究员。

2000-2008就职于Neurocrine Biosciences,任资深研究员。

2008-2012就职于BioDuro, a PPD Company,历任总监,资深总监,执行总监。

2012年初加入苏州大学,任特聘教授,博士生导师。

2018年创建爱科诺,任首席执行官。


公司简介:


Accro Bioscience is a Suzhou, China based innovative biotechnology company dedicated to the development of next generation therapeutics for inflammatory/autoimmune diseases and cancer. The current focus of Accro Bioscience is regulated cell death (e.g. necroptosis, pyroptosis) and related pathology. Accro Bioscience was founded by a group of experts in cell death and drug development. The company has strong support from the venture capital community with Morningside as the main investor.